List of articles in "Drug" category - Page 283

Atrasentan is an experimental drug that is being studied for the treatment of various types of cancer including non-small cell lung cancer.It is an endothelin receptor antagonist selective for subtype […]

Atiprimod (INN codenamed SK&F106615) is a substance being studied in the treatment of certain multiple myelomas and other advanced cancers. It may block the growth of tumors and the growth […]

Atamestane is an aromatase inhibitor that is being studied in the treatment of cancer. Atamestane blocks the production of the hormone estrogen in the body.It is selective.

Tezosentan is a non-selective ETA and ETB receptor antagonist. It acts as a vasodilator and was designed as a therapy for patients with acute heart failure. Recent studies have shown […]

Ibudilast (development codes: AV-411 or MN-166) is an antiinflammatory drug used mainly in Japan which acts as a phosphodiesterase inhibitor inhibiting the PDE-4 subtype to the greatest extent but also […]

Proglumide (Milid) is a drug that inhibits gastrointestinal motility and reduces gastric secretions. It acts as a cholecystokinin antagonist which blocks both the CCKA and CCKB subtypes. It was used […]

Amrubicin (INN; previously known as SM-5887) is an anthracycline used in the treatment of lung cancer. It is marketed in Japan since 2002 by Sumitomo Pharmaceuticals under the brand name […]

Imexon (INN trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer including pancreatic lung breast prostate melanoma and multiple myeloma. It […]

Amonafide (originally AS1413) (INN trade name Quinamed) is a drug that is being studied in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and […]

Lapaquistat (TAK-475) is a cholesterol-lowering drug. Unlike statins which inhibit HMG-CoA reductase lapaquistat metabolites inhibit squalene synthase which is further downstream in the synthesis of cholesterol.